Journal Guide

Thyroid, the Official Journal of the American Thyroid Association, is the leading resource for thyroidologists, endocrinologists, and internal medicine specialists to stay abreast of current reviews, commentaries, and clinical management strategies on all aspects of thyroid disease and treatment.The Journal is an indispensable resource for endocrinologists to stay up to date on the latest studies on thyroid diseases (thyroid dysfunction, workup of thyroid nodules, management of thyroid cancer), and other common disorders encountered in endocrine practice.Relevant for researchers in cell biology (autoimmunity, signaling, and hormone action), physiology, carcinogenesis, development, and genetics, Thyroid is also critical to a wide range of specialties including: internal medicine, endocrine surgery, pediatrics, OB/GYN, radiology, nuclear medicine, and pathology.Entering its 21st year, Thyroid remains unique in blending basic papers, clinical studies, and patient-focused reports, and is:* The repository for the best peer-reviewed translational research and clinical management in the field, offering online ahead-of-print publication* Covers all aspects of thyroid disease from primary care to clinical research* Global in scope, providing access to the most current research worldwide* The exclusive source for the Authoritative and Updated ATA Guidelines for Managing Thyroid Disease.

Thyroid Research is devoted to all aspects of thyroid hormones and thyroid diseases and their interaction with the cardiovascular, pulmonary, gastroenterological, metabolic and nervous systems.

Tissue Antigens publishes full-length original articles, brief communications, commentaries and reviews covering all aspects of genetic control of immunity. The scope includes functional, biochemical, and genetic studies on molecules of the immune system, including cell surface receptors and their ligands, and encompassing cytokines, and chemokines, adhesion and co-stimulating molecules, antigen receptors such as TcR, NKR, CD1, PAMPs, Igs, and genes and products of the major histocompatibility complex including classical and non-classical HLA molecules. Papers should describe original research in vitro, or in animal models, or be clinical studies reflecting genetics of immunity in solid organ or bone marrow transplantation, autoimmunity, infectious immunity, allergy, tumour immunity, vaccine science, pregnancy and disease susceptibility. The journal emphasis is on understanding genetic control of immunity through:.

Aims & Scope: Tissue Barriers is the first international cross-disciplinary journal that focuses on the architecture, biological roles and regulation of tissue barriers and intercellular junctions. We publish high quality peer-reviewed articles that cover a wide range of topics including structure and functions of the intestinal, airway, renal, epidermal and other types of tissue barriers, biology of  blood-brain and blood-testis barriers, molecular composition and dynamics of epithelial and endothelial junctions, leukocyte, tumor cell and pathogen interactions with epithelial and endothelial layers, non-cellular components of tissue barriers, barrier dysfunctions in diseases and drug delivery across epithelial and endothelial barriers.

Tissue Barriers publishes several categories of articles including: Original Research Papers, Short Communications, Technical Papers, Reviews, Perspectives and Commentaries, Hypothesis and Meeting Reports. Reviews and Perspectives/Commentaries will typically be invited. We also anticipate to publish special issues that are devoted to rapidly developing or controversial areas of research. Suggestions for topics are welcome.

Tissue Barriers has several goals:

• To promote cross-disciplinary awareness and collaborations between researchers working with different types of epithelial and endothelial barriers and build a broad and cohesive worldwide community of scientists interesting in this exciting field.
• To comprehend the enormous complexity of tissue barriers and map cross-talks and interactions between their different cellular and non-cellular components.
• To highlight the roles of tissue barrier dysfunctions in human diseases and accelerate a search for pharmacological enhancers of tissue barriers as potential therapeutic agents.
• To understand and optimize drug delivery across epithelial and endothelial barriers.

Publication office: Taylor & Francis, Group, 530 Walnut Street, Suite 850, Philadelphia, PA 19106. 

Tissue Engineering is the premier biomedical journal that brings together the principles of engineering and life sciences to generate new tissue development. It is a forum for groundbreaking scientific research and clinical application from the leading experts in the field. This multidisciplinary journal publishes cutting-edge, breakthrough research and applications on all aspects of tissue growth and regeneration.Anthony Atala, member of the Executive Editorial Board, when interviewed on a 60 Minutes segment, spoke about Regenerative Medicine and current developments in growing body parts. Dr. Atala is the director at Wake Forest Institute for Regenerative Medicine, which is currently growing various tissues for regenerating several body parts including bladders and kidneys, providing endless possibilities for the future of this field.During the interview, Dr. Atala explained “…the hope of the field is that some day we can provide replacement tissues and organs that can be used to help transplant patients who are waiting for organs to survive. Every organ in our body contains special stem cells that are unique to each body part. The key to regeneration is to isolate and then multiply those cells until there are enough to cover a mold of that particle body part.” The field of tissue engineering provides infinite possibilities in bioengineering and life science processes. .

issue Engineering is the premier biomedical journal that brings together the principles of engineering and life sciences to generate new tissue development. It is a forum for groundbreaking scientific research and clinical application from the leading experts in the field. This multidisciplinary journal publishes cutting-edge, breakthrough research and applications on all aspects of tissue growth and regeneration.Anthony Atala, member of the Executive Editorial Board, when interviewed on a 60 Minutes segment, spoke about Regenerative Medicine and current developments in growing body parts. Dr. Atala is the director at Wake Forest Institute for Regenerative Medicine, which is currently growing various tissues for regenerating several body parts including bladders and kidneys, providing endless possibilities for the future of this field.During the interview, Dr. Atala explained “…the hope of the field is that some day we can provide replacement tissues and organs that can be used to help transplant patients who are waiting for organs to survive. Every organ in our body contains special stem cells that are unique to each body part. The key to regeneration is to isolate and then multiply those cells until there are enough to cover a mold of that particle body part.” The field of tissue engineering provides infinite possibilities in .

Tissue & Cell is devoted to original research on the organization of cells, their components and extracellular products, at all levels including the grouping and interrelations of cells, in tissues and organs. Emphasis is placed on cell biological aspects of structure, function and behaviour of cells, and primarily morphological accounts must include substantially new information of general interest. Timely review articles on topics of particular interest, and accounts of new techniques and applications that deal with aspects of cell structure and function are invited.A new service for Authors - Submit your article onlineTo order this journal online, visit http://intl.elsevierhealth.com/journals/ticeBenefits to authorsWe also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services.Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our support pages: http://support.elsevier.com

Toxicologic Pathology focuses on the multidisciplinary elements that constitute toxicologic pathology, including spontaneous and experimentally induced morphological and functional changes, environmental exposures, case reports, and risk assessment and investigative techniques. The journal publishes original articles, symposia papers, brief communications, current topic reviews, current issues, and fast-track articles.

Traffic encourages and facilitates the publication of papers covering the cell biology of intracellular transport in health and disease. Areas of interest include protein, nucleic acid and lipid traffic, molecular motors, intracellular pathogens, intracellular proteolysis, nuclear import and export, cytokinesis and the cell cycle, protein translocation, antigen processing and presentation, organelle biogenesis, cell polarity and organization, and organelle movement.All aspects of the structural, molecular biology, biochemistry, genetics, morphology, intracellular signaling and relationship to hereditary or infectious diseases will be covered. Manuscripts must provide a clear conceptual or mechanistic advance. The editors will reject papers that require major changes, including addition of significant experimental data or other significant revision.Traffic will consider manuscripts of any length, but encourages authors to limit their papers to 16 typeset pages or less.

Transfusion Clinique et Biologique publishes original papers, general reviews, clinical cases, letters to the editor and editorials concerning transfusion activity in all its scientific and medical aspects.
Articles in English are also accepted.
In the CME section, update articles are published, together with self-evaluations and litterature reviews.

Benefits to authors
We also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our http://www.elsevier.com/wps/find/authorsview.authors/authorservicesauthor services.

Please see our http://www.elsevier.com/wps/find/journaldescription.cws_home/623385/authorinstructionsGuide for Authors for information on article submission. If you require any further information or help, please visit our support pages: http://support.elsevier.com

Transgenic Research publishes research in transgenic higher organisms including their production, properties resulting from the transgenic state, use as experimental tools, exploitation and application, and environmental impact. The journal bridges the gap between fundamental and applied science in molecular biology and biotechnology.
Coverage includes studies on transgenic animals and plants in which insertion of transgenes including modification of endogenous genes, by any route or vehicle, has been used to confer novel metabolic or developmental properties on the organism. Investigations into the physiology, biochemistry, molecular biology, development, genomics, genetics, behaviour and exploitation of such transgenic organisms are also covered. Transgenic Research provides a valuable forum for the cross-fertilization of ideas and techniques in all areas of transgenic technology from fungi to higher eukaryotic organisms.

Translational Oncology publishes the results of novel research investigations which bridge the laboratory and clinical settings including risk assessment, cellular and molecular characterization, prevention, detection, diagnosis and treatment of human cancers with the overall goal of improving the clinical care of oncology patients. Translational Oncology will publish laboratory studies of novel therapeutic interventions as well as clinical trials which evaluate new treatment paradigms for cancer. Peer reviewed manuscript types include Original Reports, Reviews and Editorials.

Tree Genetics and Genomes is an international peer-reviewed journal offering state-of-the-art coverage in all areas of theoretical and applied tree genetics. The editors are committed to making a significant, ongoing contribution to the advancement of tree genetics. Key topics include studies in horticultural and forest tree genomics (functional and comparative); genetic diversity and conservation genetics; molecular genetics, evolutionary genetics and population genetics; tree/forest breeding studies (forest/urban/ornamental/horticultural trees) and bioinformatics.
The journal is ideally suited for scientists, researchers and students desiring reliable, accurate coverage of classical genetic approaches, molecular biological approaches, and newer disciplines such as functional genomics.5-Year Impact Factor: 2.978 (2012)*

Tree Physiology publishes both technical reviews and original research reports on all aspects of physiology of trees, other woody species, and species of arborescent growth forms (a full list of topics can be found in our Instructions to Authors). Tree Physiology is a refereed journal distributed internationally.Tree Physiology was founded in 1986 by Alfred Burdett and Rozanne Poulson of Heron Publishing. Under their management, the journal grew in both size and reputation to become one of the top-ranking journals in the field. Oxford Journals will continue to build on this solid foundation and ensure wider dissemination and further development of Tree Physiology.Scope of the JournalTree Physiology promotes research in a framework of hierarchically organized systems, measuring insight by the ability to link adjacent layers: thus, investigated tree physiology phenomenon should seek mechanistic explanation in finer-scale phenomena as well as seek significance in larger scale phenomena (Passioura 1979). A phenomenon not linked downscale is merely descriptive; an observation not linked upscale, might be trivial. Physiologists often refer qualitatively to processes at finer or coarser scale than the scale of their observation, and studies formally directed at three, or even two adjacent scales are rare. To emphasize the importance of relating mechanisms to coarser scale function, Tree Physiology will highlight papers doing so particularly well as Feature Papers.Tree Physiology welcomes submissions of manuscripts on research of non-tree woody and arborescent species (shrubs, vines, tree ferns, palms, bamboo). It invites submissions on new methods designed to improve estimates of quantities of structural components and flux of matter, energy and information relevant to the structure and the function of these species.Tree Physiology also welcomes those manuscripts on genomics demonstrating a clear link and relevance to tree physiology.Authors who prepared short, hard-hitting manuscripts are encouraged to submit them as Tree Physiology Letters that will be fast tracked through the review process with the help of the Editorial Review Board.

Trees - Structure and Function publishes original papers on the physiology, biochemistry, functional anatomy, structure and ecology of trees and other woody plants. Also presented are articles concerned with pathology and technological problems, when they contribute to the basic understanding of structure and function of trees. In addition to original papers and short communications, the journal publishes reviews on selected topics concerning the structure and function of trees. The Founding Editor of Trees - Structure and Function is Hubert Ziegler. The Editors-in-Chief are Robert D. Guy, Department of Forest Sciences, University of British Columbia, Vancouver, Canada, and Ulrich E. Lüttge, Botanisches Institut der TU, Darmstadt, Germany.5-Year Impact Factor: 2.072 (2012)*